AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

OraSolv technology.(RXs)(Cima Labs Inc.)(Brief Article)

Chain Drug Review

| September 26, 2005 | COPYRIGHT 2005 Racher Press, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

Cima Labs Inc. says OraSolv, its orally disintegrating drug delivery technology, will be incorporated in a version of Schering-Plough Corp.'s Clarinex Reditabs. Schering recently received FDA ...

Related articles from newspapers, magazines, journals, and more
S-P to begin distribution of drug using CIMA's OraSolv.(Schering-Plough Corp.,...
Newspaper article from: Pharma Marketletter September 5, 2005 700+ words
CIMA LABS, a division of US biotechnology firm...drug delivery technology developed by CIMA LABS. The novel formulation was approved...Clarinex Reditabs is a good example of CIMA LABS' drug delivery innovation, enhancing...
Cephalon promotes Raj Khankari at CIMA Labs unit.(Brief article)
Newspaper article from: Pharma Marketletter December 22, 2006 700+ words
US biopharmaceutical firm Cephalon has promoted Raj Khankari to the post of general manager at its Minneapolis-based CIMA Labs drug-delivery technology subsidiary. Dr Khankari will retain his current responsibilities as vice president of worldwide drug delivery technology.
KV Pharma prevails in CIMA/Schwarz DuraSolv patent case.(KV Pharmaceutical...
Newspaper article from: Pharma Marketletter May 3, 2004 700+ words
...Pharmaceutical says that the US District Court for the District of Minnesota has denied a motion for a preliminary injunction filed by CIMA Labs and Schwarz Pharma, in a patent infringement action brought against KV and its subsidiary, ETHEX Corp. The Court's order...
Cephalon and CIMA merger agreed by FTC in principle.(CIMA LABS Inc., Federal...
Newspaper article from: Pharma Marketletter July 12, 2004 700+ words
...agreement in principle with the Federal Trade Commission, subject to final approval, for the company's proposed merger with CIMA Labs. As a result, both companies have waived their respective rights to terminate the merger agreement and intend to close this...
CIMA Labs plans $35 million plant overhaul.(Brief Article)
Newspaper article from: Finance and Commerce Daily Newspaper, MN August 1, 2002 700+ words
Byline: F&C Staff CIMA Labs will soon renovate facilities in Brooklyn Park and Eden Prairie, spending $35 million to accommodate an expanding product pipeline...
President, CEO of CIMA Labs to retire.(John M. Siebert)(Brief Article)
Newspaper article from: Finance and Commerce Daily Newspaper, MN March 19, 2002 700+ words
Byline: F&C Staff Eden Prairie-based CIMA Labs Inc. (Nasdaq:CIMA) Monday announced that John M. Siebert will retire on Dec. 31, 2003 as president and chief executive...
CIMA LABS' OraSolv(R) Technology Used in CLARINEX(R) (desloratadine)...
Press release article from: PR Newswire August 25, 2005 700+ words
...Aug. 25 /PRNewswire-FirstCall/ -- CIMA LABS INC., a Cephalon company , announced...drug delivery technology developed by CIMA LABS. Schering-Plough announced in July...CLARINEX Reditabs is a good example of CIMA LABS' drug delivery innovation, enhancing...
CIMA LABS Inc. Reports Year-End and Fourth Quarter 1997 Financial Results
Press release article from: PR Newswire February 19, 1998 700+ words
...Minn., Feb. 19 /PRNewswire/ -- CIMA LABS INC. (Nasdaq: CIMA) today announced...President and Chief Financial Officer of CIMA LABS INC. Total revenues for the year ended...President and Chief Executive Officer of CIMA LABS INC. "The Company enjoyed its first...
Cima Labs receives proposal from Cephalon Inc for alternative transaction.
News wire article from: Asia Africa Intelligence Wire August 21, 2003 700+ words
...Chemical Business NewsBase - Press Release) Cima Labs Inc has received a letter from Cephalon...transaction to the proposed merger of Cima Labs with aaiPharma Inc announced earlier...in which Cephalon would acquire all of Cima Labs' outstanding shares at a price of...
CIMA LABS INC. Reports Year-End and Fourth Quarter 1996 Results
Press release article from: PR Newswire February 19, 1997 700+ words
...Minn., Feb. 19 /PRNewswire/ -- CIMA LABS INC. (Nasdaq: CIMA) today announced...President and Chief Executive Officer of CIMA LABS INC. "The Company's short-term...completed our public offering in May 1996." CIMA LABS INC. develops products based primarily...
For more facts and information, see all results

Source: HighBeam Research, OraSolv technology.(RXs)(Cima Labs Inc.)(Brief Article)

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA